Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Nov;48(5):717–725. doi: 10.1038/bjc.1983.255

Lymphoma-associated antigen (LAA): isolation, characterization and clinical evaluation.

M Udayachander, A Meenakshi, J Ansamma, R Muthiah
PMCID: PMC2011531  PMID: 6315041

Abstract

Lymphoma-associated antigen (LAA) was isolated from lymph nodes of confirmed Hodgkin's and non-Hodgkin's lymphomas by saline extraction, centrifugation and ammonium sulphate fractionation and then purified by G-200 Sephadex chromatography which revealed its mol.wt at 29 K daltons. By sucrose density-gradient centrifugation the mol.wt of LAA was 43 K daltons. Physicochemical properties of LAA were determined. In polyacrylamide gel LAA separated as a discrete protein with electrophoretic mobility of alpha-globulin at pH 8.6. The pI was 5.04 and sedimentation coefficient between 3S-4S. Xenogeneic antiserum was raised in rabbits and purified by cross adsorption and affinity chromatography. By immunochemical methods, LAA was detected in the sera and body fluids of most lymphoma patients and was absent from normal individuals and patients with other types of cancer. A radioimmunoassay procedure was developed and preliminary studies revealed that the lymphoma sera at 1:5 and 1:10 dilution inhibited the binding of labelled LAA by antibody, whereas the sera of normals and controls exhibited no such inhibition. The sensitivity of this assay was 22 ng ml-1. The serum LAA levels were in the range of 187-1500 ng ml-1. These results were also confirmed by the indirect inhibition assay using conjugated peroxidase. Serial determination of serum LAA by RIA indicated a positive correlation with the course of disease.

Full text

PDF
717

Images in this article

721Figure 2
on p.721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  2. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Minowada J., Onuma T., Moore G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972 Sep;49(3):891–895. [PubMed] [Google Scholar]
  4. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  5. Nathwani B. N., Kim H., Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976 Aug;38(2):964–983. doi: 10.1002/1097-0142(197608)38:2<964::aid-cncr2820380248>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  6. Nilsson K., Pontén J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer. 1975 Feb 15;15(2):321–341. doi: 10.1002/ijc.2910150217. [DOI] [PubMed] [Google Scholar]
  7. Okamura S., Chechik B. E., Lee C., Gelfand E. W., Mak T. W. Heterogeneity of human thymocytes and a malignant T-lymphoblast cell line, MOLT-3. Cancer Res. 1981 May;41(5):1664–1668. [PubMed] [Google Scholar]
  8. Order S. E., Chism S. E., Hellman S. Hodgkin's disease-associated antigens: studies on segregation and specificities. Natl Cancer Inst Monogr. 1973 May;36:139–145. [PubMed] [Google Scholar]
  9. Pangalis G. A., Nathwani B. N., Rappaport H., Rosen R. B. Acute lymphoblastic leukemia: the significance of nuclear convolutions. Cancer. 1979 Feb;43(2):551–557. doi: 10.1002/1097-0142(197902)43:2<551::aid-cncr2820430222>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Poppema S., Elema J. D., Halie M. R. Alkaline phosphatase positive lymphomas: a morphologic, immunologic, and enzymehistochemical study. Cancer. 1981 Mar 15;47(6):1303–1312. doi: 10.1002/1097-0142(19810315)47:6<1303::aid-cncr2820470612>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  11. Porath J., Axen R., Ernback S. Chemical coupling of proteins to agarose. Nature. 1967 Sep 30;215(5109):1491–1492. doi: 10.1038/2151491a0. [DOI] [PubMed] [Google Scholar]
  12. TATARINOV Iu S. OBNARUZHENIE EMBRIOSPETSIFICHESKOGO ALPHA-GLOBULINA V SYVOROTKE KROVI BOL'NOGO PERVICHNYM RAKOM PECHENI. Vopr Med Khim. 1964 Jan-Feb;10:90–91. [PubMed] [Google Scholar]
  13. Whiteside T. L., Rowlands D. T., Jr T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol. 1977 Sep;88(3):754–792. [PMC free article] [PubMed] [Google Scholar]
  14. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yachi A., Matsuura Y., Carpenter C. M., Hyde L. Immunochemical studies on human lung cancer antigens soluble in 50 per cent saturated ammonium sulfate. J Natl Cancer Inst. 1968 Apr;40(4):663–682. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES